Polydex Pharmaceuticals Limited, through its subsidiaries, engages in the development, manufacture, and marketing of biotechnology-based products for the human pharmaceutical market; and manufacture of bulk pharmaceutical intermediates for the veterinary pharmaceutical industry worldwide. It primarily offers Dextran and derivative products, including Iron Dextran, a derivative of Dextran used for the treatment of anemia in pigs; and Dextran Sulphate, a specialty chemical derivative of Dextran used in research applications by the pharmaceutical industry and other centers of chemical research. The company sells its Iron Dextran primarily to independent distributors and wholesalers in Europe, the Far East, South America, and Canada; and Dextran Sulphate to the independent distributors and wholesalers in the United States and Europe for analytical chemical applications. It also develops Ushercell, a high molecular weight Cellulose Sulphate envisioned for topical vaginal use primarily in the prevention and transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies; and Usherdex 4 for the treatment of Cystic fibrosis, a genetic disease. The company was formerly known as Polydex Chemicals Limited and changed its name to Polydex Pharmaceuticals Limited in March 1984. Polydex Pharmaceuticals Limited was founded in 1966 and is based in Toronto, Canada.
Last updated June 12, 2013
You are attempting to access a page that requires a full Platinum Membership. Because you currently have access to and receive our Premium Alerts, we believe the ability to read why we issue our alerts is invaluable.
Our alerts reference every facet of our research:
- Premium emails
- RFT's (Reasons for Tracking)
- In-depth due diligence reports
- Spotlight research updates
- Positions Screens & Mock Portfolios
Because you have already subscribed to our Premium Alert service, we are happy to extend to you an upgrade at a very steep discount.
Just use code code TWEETUP12 to receive an 80% discount off our Annual Platinum plan, which blows away the current 60% discount we regularly offer.
And even better yet, you get one week to decide if it's right for you.
Upgrade Now and Join Thousands Who Read Our Research Every Day